PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Department of Pediatric Rheumatology, Ankara Children\'s Hospital, University of Health Sciences.\', \'Pediatric Intensive Care Unit, Ankara Children\'s Hospital, Ankara Yildirim Beyazit University.\', \'Department of Pediatric Intensive Care, Ankara Children\'s Hospital, University of Health Sciences.\', \'Department of Pediatric Rheumatology, Faculty of Medicine, Selçuk University.\', \'Department of Pediatric Cardiology, Ankara Children\'s Hospital, University of Health Sciences.\', \'Department of Pediatric Infectious Diseases, Ankara Children\'s Hospital, Ankara Yildirim Beyazit University.\', \'Department of Pediatric Hematology, Ankara Children\'s Hospital, University of Health Sciences.\', \'Department of Pediatric Surgery, Ankara Children\'s Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/RHU.0000000000001734
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
is ?:pmid of
?:pmid
?:pmid
  • 33843774
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Role of Biological Agents in the Treatment of SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all